Literature DB >> 24828861

Influence of rituximab plus bendamustine chemotherapy on the immune system in patients with refractory or relapsed follicular lymphoma and mantle cell lymphoma.

Kaori Ito1, Masataka Okamoto, Maiko Ando, Yukiko Kakumae, Akinao Okamoto, Yoko Inaguma, Masutaka Tokuda, Masamitsu Yanada, Shigeki Yamada, Nobuhiko Emi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24828861     DOI： 10.3109/10428194.2014.921298

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

Authors:  I F Khouri; D Sui; E J Jabbour; B I Samuels; F Turturro; G Alatrash; P Anderlini; S Ahmed; B Oran; S O Ciurea; D Marin; A Olson; K K Patel; U R Popat; C Ledesma; T M Kadia; A Ferrajoli; J A Burger; J L Jorgensen; L J Medeiros; R L Bassett; A M Gulbis
Journal:  Bone Marrow Transplant       Date:  2016-09-05       Impact factor: 5.483

2.  Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell Lymphoma.

Authors:  Kaori Ito; Masataka Okamoto; Yoko Inaguma; Akinao Okamoto; Maiko Ando; Yosuke Ando; Masahiro Tsuge; Ayana Tomono; Yukiko Kakumae; Takahiro Hayashi; Shigeki Yamada; Nobuhiko Emi
Journal:  Oncology       Date:  2016-09-29       Impact factor: 2.935

3.  A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma.

Authors:  Jeonghoon Ha; Yunhwa Jung; Yunduk Jung; Sanbin Lee; Yoonseo Lee; Insook Woo
Journal:  Blood Res       Date:  2016-03-25

4.  Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy.

Authors:  Manabu Suzuki; Daisuke Koyama; Shohei Ikeda; Masumi Sukegawa; Mayumi Teshirogi; Kyohei Misawa; Saburo Tsunoda
Journal:  J Clin Exp Hematop       Date:  2022-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.